Renal denervation for resistant hypertension-the Symplicity HTN-1 study - Authors' reply

Affiliations

¹ Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, VIC 3004, Australia. Electronic address: henry.krum@monash.edu.
² Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH, USA.
³ Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute and Heart Centre, Alfred Hospital, Melbourne, VIC, Australia.
⁴ Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinium des Saarlandes, Homburg, Germany.
⁵ Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.

Comment

Henry Krum et al. Lancet. 2014.

. 2014 May 31;383(9932):1885-6.

doi: 10.1016/S0140-6736(14)60913-2.

¹ Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, VIC 3004, Australia. Electronic address: henry.krum@monash.edu.
² Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH, USA.
³ Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute and Heart Centre, Alfred Hospital, Melbourne, VIC, Australia.
⁴ Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinium des Saarlandes, Homburg, Germany.
⁵ Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.

No abstract available

Comment on

Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.
Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD. Krum H, et al. Lancet. 2014 Feb 15;383(9917):622-9. doi: 10.1016/S0140-6736(13)62192-3. Epub 2013 Nov 7. Lancet. 2014. PMID: 24210779 Clinical Trial.
Renal denervation for resistant hypertension--the Symplicity HTN-1 study.
O'Brien E. O'Brien E. Lancet. 2014 May 31;383(9932):1884. doi: 10.1016/S0140-6736(14)60910-7. Lancet. 2014. PMID: 24881985 No abstract available.
Renal denervation for resistant hypertension-the Symplicity HTN-1 study.
Shah R. Shah R. Lancet. 2014 May 31;383(9932):1885. doi: 10.1016/S0140-6736(14)60911-9. Lancet. 2014. PMID: 24881986 No abstract available.
Renal denervation for resistant hypertension-the Symplicity HTN-1 study.
Wang Y. Wang Y. Lancet. 2014 May 31;383(9932):1885. doi: 10.1016/S0140-6736(14)60912-0. Lancet. 2014. PMID: 24881988 No abstract available.